Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-009287
Filing Date
2025-02-04
Accepted
2025-02-04 21:27:41
Documents
2
Period of Report
2025-02-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm255457-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm255457-5_4seq1.xml 4 7621
2 EXHIBIT 24 tm255457d5_ex24.htm EX-24 6267
  Complete submission text file 0001104659-25-009287.txt   15463
Mailing Address C/O GENESEE & WYOMING INC. 20 WEST AVENUE DARIEN CT 06820
Business Address
Smith Hunter C (Reporting) CIK: 0001636385 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38223 | Film No.: 25590530

Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Issuer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)